cysteine has been researched along with digoxin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Adams, GP; Bookman, MA; Hudziak, RM; Jin, D; Laminet, AA; Liu, S; McCartney, JE; Stafford, WF; Tai, MS; Weiner, LM | 1 |
Becquemont, L; Brinkmann, U; Dubert, L; El-Morabet, H; Funck-Brentano, C; Jaillon, P; Kerb, R; Strabach, S; Trugnan, G; Verstuyft, C | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Arora, S; Chaturvedi, A; Heuser, M; Joshi, G; Kumar, R; Patil, S | 1 |
1 review(s) available for cysteine and digoxin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for cysteine and digoxin
Article | Year |
---|---|
Dipyridamole enhances digoxin bioavailability via P-glycoprotein inhibition.
Topics: Adult; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cardiotonic Agents; Cross-Over Studies; Cysteine; Digoxin; Dipyridamole; Enzyme Inhibitors; Female; Genes, MDR; Genotype; Humans; Male; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Reference Values; Threonine | 2003 |
2 other study(ies) available for cysteine and digoxin
Article | Year |
---|---|
Engineering disulfide-linked single-chain Fv dimers [(sFv')2] with improved solution and targeting properties: anti-digoxin 26-10 (sFv')2 and anti-c-erbB-2 741F8 (sFv')2 made by protein folding and bonded through C-terminal cysteinyl peptides.
Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Autoradiography; Base Sequence; Cysteine; Digoxin; Disulfides; Immunoglobulin Fragments; Immunoglobulin Heavy Chains; Immunoglobulin Variable Region; Mice; Mice, SCID; Molecular Sequence Data; Neoplasms, Experimental; Peptide Fragments; Polymerase Chain Reaction; Protein Conformation; Protein Engineering; Protein Folding; Receptor, ErbB-2; Recombinant Proteins; Solubility; Sulfhydryl Compounds; Tissue Distribution | 1995 |
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
Topics: Allosteric Regulation; Allosteric Site; Carrier Proteins; Chemistry, Pharmaceutical; Glycolysis; Humans; Membrane Proteins; Protein Kinase Inhibitors; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2022 |